CYP17A1 and polycystic ovary syndrome: Nicotinamide might be partially mediated in an adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK) manner, and was found to reduce the serum testosterone levels and CYP17A1 gene expression in a letrozole-induced rat model of PCOS (37).